Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brolucizumab T&E in Pachychoroid Neovasculopathy
NCT05672979Phase 3Unknown
- Sponsor
- Yeungnam University College of Medicine
- Start
- Jan 2023
- Primary completion
- Dec 2024
- Modality
- scFv Fragments, Monoclonal Antibodies
01
Overview
A Phase 3 trial of brolucizumab in pachychoroid neovasculopathy (PNV), sponsored by Yeungnam University College of Medicine. Status: unknown.
02
Drugs
brolucizumab
03
Conditions
pachychoroid neovasculopathy (PNV)
Beyond the preview
Go deeper on NCT05672979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05672979.